28 results match your criteria: "1Massachusetts General Hospital.[Affiliation]"
Antiangiogenic agents for the treatment of glioblastoma.
Expert Opin Investig Drugs
December 2007
1Massachusetts General Hospital Cancer Center and Harvard Medical School, Department of Neurology, Boston, Massachusetts, USA.
Glioblastomas are highly vascularized and, therefore, antiangiogenic agents are increasingly being explored as therapeutic options. This review summarizes the present data on antiangiogenic agents in glioblastoma treatment. The angiogenic pathway in gliomas and the proposed mechanisms of antiangiogenic agents are reviewed briefly, and details of the drugs in clinical trial are provided.
View Article and Find Full Text PDFThe role of indirect recognition of donor MHC class II peptides in cardiac transplantation in miniature swine.
J Heart Lung Transplant
February 2001
1Massachusetts General Hospital, Boston, MA; 2Brigham and Women's Hospital, Boston, MA, USA
CTLA4Ig and donor-specific transfusion prolongs cardiac allograft survival in the miniature swine.
J Heart Lung Transplant
February 2001
1Massachusetts General Hospital, Boston, MA; 2Repligen, Needham, MA; 3Brigham and Women's Hospital, Boston, MA, USA